NEW AP127 Practical Diagnosis of Emerging Nonneoplastic Lung Diseases

8:00–11:30 am
3.0 CME CREDITS

A variety of new and evolving clinicopathologic entities have been recognized in nonneoplastic pulmonary pathology. This course provides a case-based examination of recently described entities, including criteria for diagnosis. Topics of discussion include tobacco-related interstitial lung diseases, IgG4-related lung disease, new concepts in constrictive bronchiolitis/small airway disease, acute exacerbation of chronic interstitial pneumonias, adverse pulmonary reactions to new molecular targeted therapies, and new insights into pulmonary manifestations of systemic diseases.

You will learn to:

Recognize new concepts in tobacco-related interstitial lung diseases, with particular emphasis on pulmonary fibrosis and differentiation from idiopathic interstitial pneumonias
Recognize the significance of various patterns of small airway disease, formulate a differential diagnosis, and describe emerging concepts of pathogenesis
Diagnose pulmonary manifestations of systemic diseases, including IgG4-related lung disease
Differentiate pulmonary toxicity caused by new molecular-targeted therapies from other pulmonary manifestations in patients with cancer
Recognize acute exacerbations of an underlying chronic interstitial pneumonia and discuss the potential clinical implications of making a diagnosis of this type

Faculty
Mary Beth Beasley, MD, FCAP
Philip T. Cagle, MD, FCAP

Cosponsored by